ÀϹݿ¬Á¦ : ¸ðüžÆÀÇÇÐ |
- ÀϽà : 2016³â 9¿ù 23ÀÏ (±Ý)
- Àå¼Ò : ¿¡¸Þ¶öµåȦ A[3F] |
OB01-OB05 (08:20~09:10) |
ÁÂÀå : ¿À¹ÎÁ¤(°í·ÁÀÇ´ë) |
OB0108:20~08:30 |
À̹̿µ ¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø »êºÎÀΰú |
Fetoscopic laser coagulation in twin-to-twin transfusion syndrome: A single center experience with over 100 cases |
OB0208:30~08:40 |
Á¤¿µ¹Ì ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
½Öžƿ¡¼ °èÅ뺰 ¼±Ãµ ±âÇüÀÇ ÀÏÄ¡¿¡ °üÇÑ ¿¬±¸ |
OB0308:40~08:50 |
±è´ÙÇö ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø »êºÎÀΰú |
The prevalence of Group B Streptococcus (GBS) colonization in pregnant women using selective culture
media |
OB0408:50~09:00 |
¹Ú¼ö¿¬ ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú |
The differences of microbiota composition in vaginal fluid between term and preterm
delivered women |
OB0509:00~09:10 |
ÀåÁö¾Ö ¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú |
Dickkopf-related protein 3 in cervicovaginal fluid as a novel non-invasive marker for intra-amniotic infection and/or inflammation in preterm labor or preterm premature rupture of membranes |
OB06-OB10 (09:10~10:00) |
ÁÂÀå : ±è¿µÁÖ(ÀÌÈÀÇ´ë) |
OB0609:10~09:20 |
±ÇÀÚ¿µ ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
placental TAM receptor plays a critical role in the maintenance of pregnancy by regulating
TLR mediated immune response |
OB0709:20~09:30 |
ÇÑÀ¯Á¤
|
Genome-wide gene expression analysis in the fetal trisomy 21 placenta |
OB0809:30~09:40 |
Á¤¿ë¿í Â÷ÀÇ°úÇдëÇб³ °³²Â÷º´¿ø »êºÎÀΰú |
Analysis of the cell-free amniotic fluid transcriptome expressed during the euploid mid-
trimester of pregnancy. |
OB0909:40~09:50 |
½ÉÀçÀ± ¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø »êºÎÀΰú |
Efficacy and safety of ferric carboxymaltose versus ferrous sulfate with iron deficiency anemia during pregnancy: Subgroup analysis of Korean women |
OB1009:50~10:00 |
¹®Á¾È£ Àü³²´ëÇб³º´¿ø »êºÎÀΰú |
The efficacy of 3rd generation cephalosporin plus metronidazole versus 3rd generation cephalosporin plus clarithromycin in perinatal outcomes for women with preterm premature rupture of membranes |
OB11-OB15 (10:30~11:20) |
ÁÂÀå : ¼ÕÀμ÷(°Ç±¹ÀÇ´ë) |
OB1110:30~10:40 |
±è¿µ¸® Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú |
Comparisons of obstetrical outcomes among vaginal, intramuscular progesterone treatment and conservative management for the prevention of preterm birth in twin pregnancies with a short cervix |
OB1210:40~10:50 |
ÀÌÁö¿¬ Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú |
Do reduced twin pregnancies require additional antenatal care after 20 weeks of gestation? |
OB1310:50~11:00 |
Á¤ÁöÀº Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú |
Comparison of effectiveness of progesterone and cervical cerclage for the prevention of preterm birth in twin pregnancy |
OB1411:00~11:10 |
¾È±âÈÆ °í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú |
A novel animal model for cervix excision-associated spontaneous preterm birth |
OB1511:10~11:20 |
ÀÌ°æ³ë ÇѸ²ÀÇ´ë °³²¼º½Éº´¿ø »êºÎÀΰú |
History-indicated cerclage : Indication, Perioperative outcome, operative complications and new algorithm |
OB16-OB20 (11:20~12:10) |
ÁÂÀå : ¾çÁ¤ÀÎ(¾ÆÁÖÀÇ´ë) |
OB1611:20~11:30 |
½ÉÀ翵 °í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú |
Is Preeclampsia Itself a Risk Factor for the Development of Metabolic Syndrome in the Postpartum Period? |
OB1711:30~11:40 |
±è¹Î¾Æ ¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
The value of CRP/ albumin ratio in prediction of preeclampsia and its severity |
OB1811:40~11:50 |
ÀÌ¿µÁÖ ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú |
Expression and regulation of sex steroid receptors in the placenta and its correlation with
preeclampsia |
OB1911:50~12:00 |
³ëÁØÈ£ ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú |
Differences in maternal and neonatal clinical characteristics between Gram-positive and Gram-negative early onset neonatal sepsis delivered at preterm |
OB2012:00~12:10 |
ÀÌ¿¹Èç °¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú |
Pregnancy and neonatal outcomes in Group B Streptococcus agalactiae (GBS) infection during pregnancy |
OB21-OB24 (12:10~12:50) |
ÁÂÀå : Á¤¿µÁÖ(ÀüºÏÀÇ´ë) |
OB2112:10~12:20 |
¼Àº¼® °¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú |
Perinatal outcomes in women with systemic lupus erythematosus |
OB2212:20~12:30 |
³²Áö³ª ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú |
Obstetric outcomes associated with sonographically identified large uterine fibroids |
OB2312:30~12:40 |
Ãß°æÀÚ ´ë±¸°¡Å縯´ëÇб³º´¿ø »êºÎÀΰú |
Uterine polyp and pregnancy outcome |
OB2412:40~12:50 |
À§Á¤ÇÏ °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
À¯»êÀÇ ±â¿Õ·ÂÀÌ Æó°æ±â ÀÌÈÄ ÀÚ»ì »ç°í ¹× ¿ì¿ïÁõÀÇ À¯º´À²¿¡ ¹ÌÄ¡´Â ¿µÇâ - ±¹¹Î °Ç° ¿µ¾ç Á¶»ç ÀÚ·á ±â¹Ý ¿¬±¸ |
OB25-OB28 (14:00~14:40) |
ÁÂÀå : ÃÖ¼ºÁø(¿¬¼¼¿øÁÖÀÇ´ë) |
OB2514:00~14:10 |
ÀÌ½Â¹Ì ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
Á¦¿ÕÀý°³¼ú ¿¹Á¤ ÀӽŠÁÖ¼ö¿¡ µû¸¥ ÀÀ±ÞÁ¦¿ÕÀý°³¼ú ¹× ¸ðü ÇÕº´ÁõÀÇ À§Çè |
OB2614:10~14:20 |
±è¼¼·¡ ¼º±Õ°üÀÇ´ë °ºÏ»ï¼ºº´¿ø »êºÎÀΰú |
The risk of cesarean section after trial of labor in low risk pregnancies according to maternal body characteristics |
OB2714:20~14:30 |
ȲÁö¿µ Â÷ÀÇ°úÇдëÇб³ °³²Â÷º´¿ø »êºÎÀΰú |
Outcomes of subsequent deliveries after Modified B Lynch sutures for uterine atony during cesarean section |
OB2814:30~14:40 |
ÀÌ°¡À» ÀüºÏ´ëÇб³º´¿ø »êºÎÀΰú |
The effect of combined hemostatic techniques during cesarean section in placenta previa; preliminary study |
OB29-OB32 (14:40~15:20) |
ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë) |
OB2914:40~14:50 |
°ûµ¿¿í
|
Relationship between fetal crown–rump length at 11 to 14 weeks¡¯ gestation and pregnancy outcomes |
OB3014:50~15:00 |
¹ÚÁ¤¿¬ ¼¿ïƯº°½Ã º¸¶ó¸Åº´¿ø »êºÎÀΰú |
¼³ÇÏ Misoprostol Á¤À» »ç¿ëÇÑ ÀӽŠ1ºÐ±â À¯»êÀÇ ¾à¹°Àû Ä¡·áÀÇ ¾ÈÀü¼º°ú È¿°ú, ±×¸®°í ¼º°øÀûÀÎ ¾à¹°Àû Ä¡·áÀÇ °ü·Ã ÀÎÀÚ¿¡ ´ëÇÏ¿© |
OB3115:00~15:10 |
±è¿¬Èñ °¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø »êºÎÀΰú |
The Most Commonly Reported Medication in Adverse Drug Reactions among women with
obstetric condition in South Korea |
OB3215:10~15:20 |
±è½Å¿µ °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
Prevalence of low bone mineral density and associated risk factors in Korean puerperal women |